Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comparative Study
. 2007 Oct;85(10):834-8.

HLA- A, B, DR and DQ alleles study in Tunisian patients with atopic dermatitis

Affiliations
  • PMID: 18236804
Comparative Study

HLA- A, B, DR and DQ alleles study in Tunisian patients with atopic dermatitis

Hanene Affes et al. Tunis Med. 2007 Oct.

Abstract

Background: Atopic dermatitis (AD) is a chronic inflammatory skin disease resulting from the interaction between envirommental and genetic factors. Many genes are involved in the etiopathology of AD, such as HLA genes.

Objectives: Study the association between HLA-A, B, DR and DQ genes and the AD.

Methods: HLA A and B genotyping were practised for 53 atopic dermatitis patients and 76 healthy controls using the microlymphotoxicity complement dependent technique, while HLA DR and DQ genetyping were practised for only 20 patients with AD and all the controls by PCR-SSP method.

Results: Allelic frequency of HLA A32 was significantly increased in healthy individuals compared to patients affected with AD (p = 0.02, RR = 0.24). HLA-B, DR and DQ showed no differences in distrubition between patients and controls.

Conclusion: Our study suggested that HLA-A32 could be a protective marker against atopic dermatitis for Tunisian patients, in contrast to HLA-B, DR and DQ alleles which seemed to have no importance in AD pathogenis.

PubMed Disclaimer

Similar articles

Cited by

Publication types

LinkOut - more resources